Staff Publications

  • external user (warningwarning)
  • Log in as
  • language uk
Record number 535619
Title Induction of human tolerogenic dendritic cells by 3′-sialyllactose via TLR4 is explained by LPS contamination
Author(s) Perdijk, Olaf; Joost Van Neerven, R.J.; Meijer, Ben; Savelkoul, Huub F.J.; Brugman, Sylvia
Source Glycobiology 28 (2018)3. - ISSN 0959-6658 - p. 126 - 130.
DOI http://dx.doi.org/10.1093/glycob/cwx106
Department(s) Cell Biology and Immunology
WIAS
Publication type Refereed Article in a scientific journal
Publication year 2018
Keyword(s) 3′-sialyllactose - DC differentiation - human tolerogenic DC - LPS contamination - TLR4 signaling
Abstract The human milk oligosaccharide 3′-sialyllactose (3′SL) has previously been shown to activate murine dendritic cells (DC) in a Toll-like receptor (TLR) 4-mediated manner ex vivo. In this study we aimed to investigate whether 3′SL has similar immunomodulatory properties on human DC. 3′SL was shown to induce NF-κB activation via human TLR4. However, LPS was detected in the commercially obtained 3′SL from different suppliers. After the removal of LPS from 3′SL, we studied its ability to modify DC differentiation in vitro. In contrast to LPS and 3′SL, LPS-free 3′SL did not induce functional and phenotypical changes on immature DC (iDC). iDC that were differentiated in the presence of LPS or 3′SL showed a semi-mature phenotype (i.e., fewer CD83+CD86+ DC), produced IL-10 and abrogated IL-12p70 and tumor necrosis factor-alpha levels upon stimulation with several TLR ligands. Differentiation into these tolerogenic DC was completely abrogated by LPS removal from 3′SL. In contrast to previous reports in mice, we found that LPS-free 3′SL does not activate NF-κB via human TLR4. In conclusion, removing LPS from (oligo)saccharide preparations is necessary to study their potential immunomodulatory function.
Comments
There are no comments yet. You can post the first one!
Post a comment
 
Please log in to use this service. Login as Wageningen University & Research user or guest user in upper right hand corner of this page.